Minerva Neurosciences, Inc.
Compositions and methods for treating schizophrenia

Abstract:

The disclosure provides a novel polymorph of Compound (I): ##STR00001## 2-((1-(2-(4-Fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-o- ne monohydrochloride dihydrate, i.e., Form (A) of Compound (I).HCl.2H.sub.2O. Pharmaceutical compositions comprising Form (A) of Compound (I).HCl.2H.sub.2O and related methods of treatment are also disclosed.